Method Development and Validation for Simultaneous Estimation of Samidorphan, Olanzapine in pharmaceutical Dosage Form by RP- HPLC
Keywords:
Samidorphan, Olanzapine, RP-HPLCAbstract
A simple, Accurate, precise method was developed for the simultaneous estimation of the Samidorphan and Olanzapine in bulk and pharmaceutical dosage form. Chromatogram was run through Std BDS 150 x 4.6 mm, 5mm. Mobile phase containing Buffer 0.01N Potassium dihydrogen phosphate: Methanol taken in the ratio 80:20 %v/v was pumped through column at a flow rate of 0.9 ml/min. Buffer used in this method was 0.01N Kh2po4 buffer. Temperature was maintained at 29°C. Optimized wavelength selected was 278.0 nm. Retention time of Samidorphan and Olanzapine were found to be 2.365 min and 3.108 min. %RSD of the Samidorphan and Olanzapine were and found to be 0.6% and 0.4% respectively. %Recovery was obtained as 100.29% and 100.46% for Samidorphan and Olanzapine respectively. LOD, LOQ values obtained from regression equations of Samidorphan and Olanzapine were 0.29, 0.89 and 0.04, 0.12 respectively. %Assay was obtained as 99.71% and 99.58% for Samidorphan and Olanzapine respectively. Regression equation of Samidorphan is y = 21331x + 3547.4, y = 29592x + 9783.5 of Olanzapine. Retention times were decreased and that run time was decreased, so the method developed was simple and economical that can be adopted in regular Quality control test in Industries
Published
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.